The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich. Already ...

Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences ...

27 January 2026 As quantum-enabled innovation accelerates, patentability will hinge on predictability, disclosure, and ...

New York-based firm makes its second key acquisition in weeks, as the firm pursues growth by broadening its litigation ...

Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as ...

A judge has allowed antitrust claims against the pharma giant to move forward, finding that it plausibly used bundled rebates ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content. For more information on individual ...

The court found the board applied the wrong legal standard when evaluating Guardant Health’s obviousness challenge to a University of Washington DNA sequencing patent. Already registered?